These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 32323741)

  • 21. miR‑145‑5p reduces proliferation and migration of hepatocellular carcinoma by targeting KLF5.
    Liang H; Sun H; Yang J; Yi C
    Mol Med Rep; 2018 Jun; 17(6):8332-8338. PubMed ID: 29658584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR‑23b‑3p promotes the apoptosis and inhibits the proliferation and invasion of osteosarcoma cells by targeting SIX1.
    Liu H; Wei W; Wang X; Guan X; Chen Q; Pu Z; Xu X; Wei A
    Mol Med Rep; 2018 Dec; 18(6):5683-5692. PubMed ID: 30387818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triggering mitosis.
    Crncec A; Hochegger H
    FEBS Lett; 2019 Oct; 593(20):2868-2888. PubMed ID: 31602636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-193a regulates chemoresistance of human osteosarcoma cells via repression of IRS2.
    Wang H; Zhao F; Cai S; Pu Y
    J Bone Oncol; 2019 Aug; 17():100241. PubMed ID: 31193934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of miR-136 promotes the progression of osteosarcoma and is associated with the prognosis of patients with osteosarcoma.
    Chu Y; Hu X; Wang G; Wang Z; Wang Y
    Oncol Lett; 2019 Jun; 17(6):5210-5218. PubMed ID: 31186737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CBX2 is a functional target of miRNA let-7a and acts as a tumor promoter in osteosarcoma.
    Han Q; Li C; Cao Y; Bao J; Li K; Song R; Chen X; Li J; Wu X
    Cancer Med; 2019 Jul; 8(8):3981-3991. PubMed ID: 31150156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-34a suppresses aggressiveness of hepatocellular carcinoma by modulating
    Han R; Chen X; Li Y; Zhang S; Li R; Lu L
    Cancer Manag Res; 2019; 11():2963-2976. PubMed ID: 31114344
    [No Abstract]   [Full Text] [Related]  

  • 28. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.
    Huang C; Wang Q; Ma S; Sun Y; Vadamootoo AS; Jin C
    Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-145-5p Acts as a Novel Tumor Suppressor in Hepatocellular Carcinoma Through Targeting RAB18.
    Wang B; Dong W; Li X
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819850189. PubMed ID: 31106707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-628-5p promotes growth and migration of osteosarcoma by targeting IFI44L.
    Wang JY; Wang JQ; Lu SB
    Biochem Cell Biol; 2020 Apr; 98(2):99-105. PubMed ID: 31018104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-1285-3p is a potential prognostic marker in human osteosarcoma and functions as a tumor suppressor by targeting YAP1.
    Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD
    Cancer Biomark; 2019; 25(1):1-10. PubMed ID: 31006663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR‑210‑3p regulates cell growth and affects cisplatin sensitivity in human ovarian cancer cells via targeting E2F3.
    Jin Y; Wei J; Xu S; Guan F; Yin L; Zhu H
    Mol Med Rep; 2019 Jun; 19(6):4946-4954. PubMed ID: 30957179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of long noncoding RNA TUG1 contributes to the development of laryngocarcinoma by targeting miR-145-5p/ROCK1 axis.
    Zhuang S; Liu F; Wu P
    J Cell Biochem; 2019 Aug; 120(8):13392-13402. PubMed ID: 30916820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p.
    Goeppert B; Truckenmueller F; Ori A; Fritz V; Albrecht T; Fraas A; Scherer D; Silos RG; Sticht C; Gretz N; Mehrabi A; Bewerunge-Hudler M; Pusch S; Bermejo JL; Dietrich P; Schirmacher P; Renner M; Roessler S
    Sci Rep; 2019 Mar; 9(1):4796. PubMed ID: 30886199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-145-5p Suppresses Breast Cancer Progression by Inhibiting SOX2.
    Tang W; Zhang X; Tan W; Gao J; Pan L; Ye X; Chen L; Zheng W
    J Surg Res; 2019 Apr; 236():278-287. PubMed ID: 30694767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-210 knockdown promotes the development of pancreatic cancer via upregulating E2F3 expression.
    Sun FB; Lin Y; Li SJ; Gao J; Han B; Zhang CS
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8640-8648. PubMed ID: 30575904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-148a inhibits cell proliferation and cell cycle progression in lung adenocarcinoma via directly targeting transcription factor E2F3.
    Liu J; Si L; Tian H
    Exp Ther Med; 2018 Dec; 16(6):5400-5409. PubMed ID: 30546419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-145-5p inhibits the proliferation and migration of bladder cancer cells by targeting TAGLN2.
    Zhang H; Jiang M; Liu Q; Han Z; Zhao Y; Ji S
    Oncol Lett; 2018 Nov; 16(5):6355-6360. PubMed ID: 30405771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor suppressor miR-145-5p sensitizes prolactinoma to bromocriptine by downregulating TPT1.
    Jian M; Du Q; Zhu D; Mao Z; Wang X; Feng Y; Xiao Z; Wang H; Zhu Y
    J Endocrinol Invest; 2019 Jun; 42(6):639-652. PubMed ID: 30370446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-145-5p affects the differentiation of gastric cancer by targeting KLF5 directly.
    Zhou T; Chen S; Mao X
    J Cell Physiol; 2019 May; 234(5):7634-7644. PubMed ID: 30367481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.